Multiple lipid biomarkers are linked to the development of neuropathy in patients with type 2 diabetes, a new study finds. Participants with high scores for diabetic neuropathy had changes in lipids reflecting impaired energy metabolism. Researchers say the findings bring potential to identify those with the highest risk of developing disease and facilitate more focused management.
